Loss of phosphatase CTDNEP1 potentiates aggressive medulloblastoma by triggering MYC amplification and genomic instability
Zaili Luo(Shanghai Medical College of Fudan University), Q. Richard Lu(Cincinnati Children's Hospital Medical Center), Wenhao Zhou(Guangzhou Women and Children Medical Center), Jianzhong Yu(Children's Hospital of Fudan University), Paul R. Andreassen(Cincinnati Children's Hospital Medical Center), Chuntao Zhao(Cincinnati Children's Hospital Medical Center), Dazhuan Xin(Cincinnati Children's Hospital Medical Center), Kalen Berry(Cincinnati Children's Hospital Medical Center), Martine F. Roussel(St. Jude Children's Research Hospital), Ryuichi Nishinakamura(Kumamoto University), Sean Ogurek(Cincinnati Children's Hospital Medical Center), Stefan M. Pfister(Heidelberg University), Mei Xin(Chengdu University), Marcel Kool(German Cancer Research Center), William A. Weiss(City College of San Francisco), Rohit Rao(Cincinnati Children's Hospital Medical Center), Hao Li(Children's Hospital of Fudan University), Feng Zhang(Neurosciences Institute), Liguo Zhang(East China University of Science and Technology), Guoying Huang(Children's Hospital of Fudan University), Lingli Xu(Shanghai University), Xinran Dong(Children's Hospital of Fudan University), Yunfei Liao(Union Hospital), Yifeng Lin(Xinjiang Agricultural University)
Cited by 31
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
|Genes & Development|1998|1.2k
The whole-genome landscape of medulloblastoma subtypes
|Nature|2017|1.2k